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C
oronary chronic total occlusions (CTOs) are identified in 18.4% to 20% of patients with coronary artery disease with an incidence increasing with age. 1, 2 In diabetic or heart failure patients, CTO prevalence exceeds 40%. 3, 4 Less than 10% of all CTOs are treated with percutaneous techniques. 5 The majority of patients are managed medically or referred for coronary artery bypass grafting. 5 The main reason for the limited adoption of CTO percutaneous coronary intervention (PCI) is the inferior success rate compared with PCI of nonocclusive lesions. 6 During the past decade, significant advances in dedicated materials and techniques along with increased operator experience led to a dramatic increment in success rate of CTO PCI, exceeding today 90% in expert hands with reported low complication rates. 7 Retrospective nonrandomized data suggest that successful CTO PCI is related to improved survival, improvement in anginal status and left ventricular function, increased exercise tolerance, and decreased need for coronary artery bypass grafting. 8 The European expert consensus for the rationale of CTO recanalization requires the documentation of viability and ischemia in the CTO territory. 8 The aim of the present study is to describe the evolution of the practice, procedural outcome, and inhospital events after CTO PCI performed by a group of experienced CTO operators, members of the Euro CTO Club.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results. The European Registry of CTO is an electronically based, monitor-controlled registry developed by the Euro CTO Club to collect data from patients with ≥1 CTO lesions in major coronary arteries treated by 53 operators at dedicated centers across Europe (see the Data Supplement). All these operators are experienced in CTO treatment fulfilling the Euro CTO Club criteria for full membership (total experience of 300 CTOs, minimum number of 50 CTOs per year). The treatment indication was left at the discretion of the operator and was symptomatic myocardial ischemia or evidence of reversible myocardial ischemia by perfusion imaging or stress testing, according to the Euro CTO Club position paper. 8 In this database, anonymized demographic data and procedural details are prospectively collected (see the Data Supplement). Patients are requested to sign informed consent before the procedure. The study was approved by the institutional review board of each center and performed in accordance with the Declaration of Helsinki.
Definitions
A coronary CTO is defined as a total occlusion in a coronary artery with noncollateral Thrombolysis in Myocardial Infarction (TIMI) flow grade 0 of at least 3-month duration. 8 Patients were considered to have undergone retrograde CTO PCI if a guidewire was introduced into a collateral channel that supplied the target vessel. A procedure was defined as an antegrade wire escalation (AWE) if no guidewire was introduced into a collateral channel, as defined previously. A procedure was defined as antegrade dissection reentry (ADR) if wire or device-based vessel dissection was adopted as part of CTO recanalization strategy, either primarily or as bailout. Procedural success was defined as angiographic success (final residual stenosis <20% by visual estimation and TIMI flow grade 3 after CTO recanalization). Clinical success was defined as a procedural success without periprocedural complications. In-hospital major adverse cardiac events (MACEs) were defined as the composite of non-Q-wave and Q-wave myocardial infarction, recurrent angina requiring urgent repeat revascularization with PCI or coronary artery bypass grafting, stroke, death, pericardiocentesis, or surgical drainage of pericardial hematoma. Any periprocedural complication was defined as the composite of death, myocardial infarction, stent thrombosis, stroke, vessel perforation, vascular access complications, need for emergency surgical intervention or PCI, and hemoglobin reduction by >3 g/dL. 
Statistical Analysis
IBM SPSS Statistics v.25 software package (IBM Corporation, NY) and R language were used for all analyses. Two-sided P values of <0.05 were considered as indicative of statistical significance. Population and procedural characteristics (Tables 1 and 2) 
WHAT THE STUDY ADDS
• We describe the evolution of CTO practice in Europe that is potentially different from the practice in other continents.
• Currently, CTO percutaneous coronary intervention evolution is driven by technology development, primarily guidewire technology and secondary microcatheter development.
• We confirm recent data on increased complication rates related to CTO procedures, which until recently have been underreported in the literature.
variables) or the Cochran-Armitage test (for categorical ones). Generalized linear models (GenLinMs) were used to assess the combined effect of operator and time on the dependent variables. The linear effect of time was tested via the polynomial contrast with the Bonferroni adjustment for multiple comparisons, using the corresponding option of GenLinMs in SPSS (estimated marginal means). Although the reported results are based on analysis of original data, analyses were repeated after accounting for missing values, using multiple imputation methods, to confirm that the original results were not sensitive to missing value-related bias.
RESULTS

Patient and Lesion Characteristics
During a time period of ≈8 years (January 1998 to June 2015), the 53 operators that contribute data to the European Registry of CTO entered 17 626 CTO PCI procedures ( Figure 1 ). The population characteristics divided according to the procedure period are summarized in Table 1 . Over time, patients had a trend to be older, with higher prevalence of diabetes mellitus, hypertension, and renal failure. Most CTOs were located in the right coronary artery followed by the left anterior descending coronary artery. There was a substantial increase in the proportion of in-stent CTOs. The occlusion duration, when available, and CTO length also increased over time (Table 1) . Prior failed attempt was observed in 24.3% of the cases.
In terms of procedural characteristics, there were small, albeit significant, increases in procedural duration and fluoroscopy time and a decrease in contrast volume ( Table 2) . ArtG indicates arterial graft; BMI, body mass index; CABG, coronary artery bypass grafting; CTO, chronic total occlusion; J-CTO, Multicenter CTO Registry of Japan; LAD, left anterior descending; LCx, left circumflex; LMA, left main artery; MI, myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; and VenG, venous graft.
Procedural Success
Procedural success rate increased over time, from 79.7% in 2008 to 89.3% in 2015 (P<0.001; Figure 2A ). Both operator and time significantly affected procedural outcome (P for both, <0.001). AWE was applied in 76.9% of the successful cases; ADR and retrograde were adopted in the rest 3.6% and 19.5% of the successful cases, respectively. The variation of success rates by recanalization strategy (AWE, ADR, and retrograde) and access route (radial, femoral) is summarized in Figure 2B and 2C. Cases with prior failed attempt had evolving success rate over time ( Figure 2D ). In-stent CTOs were observed in 7.4% of lesions with success rate of 87.2%, persistently high during the entire study period.
Recanalization Approach and Techniques
During the study period, the rate of retrograde approach increased from 10.1% in 2008 to 29.9% in 2014 to 2015 (P for trend, <0.001). The retrograde approach was even higher in previously failed CTOs (35.9% during the study period; Table 2 ). The Corsair microcatheter Table 2 .
Guidewires
The number of guidewires used grew steadily from 3. 
J-CTO Score
The J-CTO score increased from 1.76±1.03 in 2008 to 2.17±0.91 in 2015 (P for trend, <0.001; Figure 4A ). The mean J-CTO score in failed cases was 2.37±1.14 versus 2.08±1.15 in successful ones (P<0.001). Despite its statistically significant association with procedural success, J-CTO score predictive performance was poor, when adjusting for time and operator effect (GenLinMs).
In retrograde techniques, the mean J-CTO score was similar in failed and successful cases (2.76±1.15 versus 2.65±1.12; P=0.057)-a finding consistent over the entire study period, suggesting no predictive ability of J-CTO score to retrograde ( Figure 4B ).
Complications
In-hospital mortality was low, ranging from 0.4% to 0.1% (P for time, 0.120; P for operator, 0.999; Figure 5A ). In-hospital MACE rate was 0. A, Procedural success rate during the study period (P<0.001 for time and operator). B, Recanalization approach (antegrade wire escalation, antegrade dissection reentry, and retrograde) and procedural success trend during the study period (P<0.001 for time, operator, and adopted strategy). C, Vascular access (radial vs femoral) and impact on the success rate (P<0.001 for time and operator, P for vascular access, 0.436). D, Initially attempted and previously failed chronic total occlusions (CTOs); procedural success trend during the study period (P<0.001 for time, operator, and previously failed attempt).
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2014 to 2015 (P for time, 0.034; P for operator, 0.003). MACE rate for retrograde was 0.8%, slightly higher compared with AWE (0.6%) and ADR (0.6%; P=0.217). Overall, the rate of any periprocedural complication ( Figure 5A ) remained essentially unchanged throughout the study period, ranging from 5.2% to 4.4% (P for time, 0.793), and it was significantly affected by the operator (P<0.001). Complication rate and in-hospital mortality were higher in unsuccessful cases ( Figure 5B ). In-stent CTO complication rate was 4.7% (P for operator, <0.001; P for time, 0.760). Vessel perforations increased over time (from 2.5% in 2008-2009 to 3.2% in 2014-2015; P for time, 0.224; P for operator, 0.99); however, pericardiocentesis or surgical intervention was only needed in 0.4% of patients overall. The complication rate trend according to the strategy adopted (AWE, ADR, and retrograde) is summarized in Figure 5C and 5D.
DISCUSSION AND LIMITATIONS
Our study evaluates the temporal trends in CTO recanalization in Europe, reporting in-hospital data during an 8-year period of 17 626 procedures performed by 53 operators, full members of the Euro CTO Club. The main findings of the study are the following: (1) CTO PCI success rates are steadily increasing, despite the increasing complexity of the lesions attempted. (2) J-CTO score predictive value for procedural success is low for the entire cohort, and it has no predictive ability for the retrograde procedures. (3) In-hospital complication rates are stable but higher compared with that reported in other registries. (4) Retrograde approach significantly increased with low in-hospital complication risk. (5) Intermediate stiffness guidewire use is increasing related to wire technology evolution and technique standardization. (6) IVUS use is steadily increasing. (7) ADR, wire based and device based, adoption in Europe is low.
Procedural Success
Based on the membership criteria of Euro CTO club, patients in this registry were treated by experienced CTO operators, and this is reflected in procedural outcome ( Figure 2) . Results from the National Cardiovascular Data Registry indicated increasing success rates over time, from 55.5% in 2009 to 61.9% in 2013. 10 Procedural success for high-volume operators was 81%. 10 In a meta-analysis of 18 061 patients from 65 studies published in the period . 11 Yet, during the past years, dedicated groups of experts worldwide consistently report high success rates, up to 91%, matching the results of our study. 5, 7, 9, [12] [13] [14] Lesion Complexity, J-CTO Score, and Novel Predictive Models A recent report from the J-CTO registry indicated that J-CTO score was able to predict successful lesion crossing.
14 A study from the United States also reported significant association between J-CTO score and final technical success rate. 15 In contrast, in patients treated with the hybrid approach, 16 the J-CTO score was not associated with final success rate. Newer scores have been proposed to better reflect contemporary CTO practice. The PROGRESS CTO score (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention), focusing on the hybrid approach, performed similarly to J-CTO score in predicting technical success. 17 The CL score (clinical and lesion related), with both clinical and angiographic variables, outperformed J-CTO score in predicting procedural success. 18 A comparison of the J-CTO, PROGRESS CTO, and CL scores indicated that they perform moderately in predicting technical outcome of CTO PCI, with better performance for antegrade-only procedures. All 3 scores did not perform well for procedures in which a retrograde approach was used.
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Dedicated CTO Wires, Evolution, IVUS
Guidewire technology largely evolved through the study period and contributed in technique evolution and overall procedural efficiency. 20 In the early era of CTO PCI, stiff wires were predominantly used for lesion crossing. Wires with high-penetration power suffered from incapacity to deflect and poor steerability in tortuous anatomy. In 2008, low tip stiffness (<1 g) in combination with tapering and polymer and hydrophilic coating were introduced (Fielder XT; Asahi Intecc, Japan). Low tip stiffness wires were proven good for soft tissue tracking, A, J-CTO score trend during the study period (P for trend, <0.001). B, J-CTO score and its association with the procedural outcome (P for time and operator, <0.001; P for retrograde success, >0.05). The P values that correspond to comparisons between successful and failed cases (for each 2-y period, in the entire cohort and separately in retrograde cases) are P<0.001 for the entire cohort, and P>0.05 for the retrograde cases (for all 2-y periods). It is evident that, in patients treated with retrograde techniques, J-CTO was similar in failed and successful cases.
offering a success rate of 30% to 40%, but they tended to overdeflect and were also not steerable in more complex anatomy. Composite core technology became available in 2010 to 2011 (Asahi Sion family) dramatically increasing wire steerability and tip shape retention and was introduced in the low stiffness wires to improve their performance (Fielder XTA/Fielder XTR; Asahi Intecc, Japan). Growing experience and understanding of CTOs through the years made evident that penetration power and steerability can only be combined to intermediate stiffness wires. In 2013, combination of composite core tapering polymeric and hydrophilic coating in intermediate stiffness wires introduced the deflection and rotation concept that prevailed in modern CTO wiring (GAIA family). The use of these wires dominated the last period the practice in Europe and will keep on increasing in all anatomies except heavily calcified lesions, where stiff wires are indispensable.
IVUS utilization increased over time but remains low because of reimbursement limitation in Europe. Interestingly, Kim et al 21 in a randomized study demonstrated that IVUS-guided CTO intervention did not significantly reduce cardiac mortality, but improved 12-month MACE rate, when compared with angiography-guided CTO PCI.
Retrograde Approach, ADR
The European experience with the retrograde approach (2008-2012) has been recently reported. 22 Retrograde approach in our study increased mainly because of the evolution of microcatheter and collateral crossing dedicated wires. This observation is in concordance with the experience in other continents. In the J-CTO registry, retrograde approach utilization was 23%. 23 A meta-analysis of 18 061 patients from 65 studies revealed that retrograde techniques were used in 26.4% of the patients attempted. 12 ADR adoption, both device based and wire based, in Europe remains low, in the range of 5.5%. A much higher rate of adoption (in the range of 20%) is reported in other registries. 7, [24] [25] [26] The ADR concept was revolutionized in the United States and included in the hybrid algorithm, which was not widely accepted in other continents. Another explanation is the variable reimbursement policies among European countries that certainly did not help in the adoption of device-based ADR. Europe was always more retrograde oriented.
Complication Rate
During a long period of time, CTO PCI complication rates were reported in the range of 2%.
27,28 A recent A, Any procedural complication (P for time, 0.793; P for operator, <0.001) and in-hospital mortality (P for time, 0.120; P for operator, 0.999) during the study period. B, Comparison of any periprocedural complication (P for operator, <0.001; P for successful outcome, <0.001; P for time, >0.05) and in-hospital mortality (P for operator, 0.76; P for successful outcome, <0.001; P for time, >0.05) to successful vs failed chronic total occlusion percutaneous coronary intervention. The P value that corresponds to the χ 2 test for the comparison between successful and failed cases in each 2-y period is P for all <0.001. C, Any periprocedural complication rate according to the recanalization approach (antegrade wire escalation [AWE], antegrade dissection reentry [ADR], and retrograde); P for adopted strategy, <0.001; P for operator, <0.001; P for time, >0.05. D, Any periprocedural complication trend according to the recanalization approach (AWE, ADR, and retrograde); P for adopted strategy, <0.001; P for operator, <0.001; P for time, >0.05. systematic review reported low and decreasing rates of CTO PCI complications over time, despite increasing success rates (pooled estimate, 3.1%). 11 A report from the National Cardiovascular Data Registry (594 510 patients) revealed 1.6% CTO PCI MACE rate, decreasing over time, but higher compared with non-CTO PCI procedure MACE rate (0.8%). Higher volume CTO PCI operators had lower MACE rates. 10 In a multicenter Japanese registry, the MACE rate was 3.2%. 23 In a recent meta-analysis, the overall perforation rate reported was 2.9% with an increase to 3.2% in patients treated with retrograde techniques. 12 In our study, complication rates were operator dependent (P<0.001) and remained essentially unchanged throughout the study period, ranging from 5.2% to 4.4% (P for time, 0.793; Figure 5A ), definitely higher compared with that reported in literature. Unsuccessful cases had higher complication rate ( Figure 5B )-a finding consistent with the results of other contemporary registries. 2 Retrograde approach had higher complication rate, compared with AWE and ADR ( Figure 5C and 5D), but comparable MACE rate.
European Registry of CTO is a prospective registry of expert operators reflecting more accurately the contemporary practice, compared with registries reporting on retrospective data. The recently reported OPEN CTO registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures), core-lab adjudicated, accommodates our findings. MACE reported was 7%; in-hospital mortality, 0.9%; myocardial infarction, 2.6%; emergent surgery, 0.7%; acute kidney injury, 0.7%; radiation injury, 0.1%; and perforations, 8.8%. 29 Recently, there is an awareness that CTO PCI complication rates might have been underreported in the literature.
Study Limitations
European Registry of CTO is an evolving registry and as such it adapts to CTO PCI evolution. During 2008 to 2013 ADR terminology was not internationally standardized; therefore, ADR was not in the database. ADR utilization during this period might have been underreported because of the lack of ADR standardized definition. What was available in that period was the use of ADR devices (Stingray or Crossboss) and wire-based dissection reentry techniques, like the subintimal tracking and reentry technique. ADR during 2008 to 2013 was calculated extracting these parameters. ADR has been adopted at the database since the end of 2013. The contribution of ADR and retrograde to the procedural success rate might be overestimated because of definition limitations in cases where more than one technique (AWE, ADR, and retrograde) has been applied. Similarly, complications attributed to ADR or retrograde might be lower than reported.
All patients in our registry were treated by experienced CTO operators. The data presented in this manuscript reflect their practice and cannot be generalized for nondedicated European centers. As is the case with most large-scale registries, each center is responsible for the accuracy and completeness of entered data, without post hoc reappraisal of cases and confirmation of data. This may lead to some degree of reporting bias, but the large number of procedures in the current study and the fact that certain important metrics, such as success rate, are comparable with previous reports suggest good consistency and reliability of collected data.
Conclusions
CTO PCI evolved for a decade and is reaching a period of standardization in terminology and practice. Patients with increasing comorbidities and lesion complexity are currently treated with a success rate of >90%. Many lessons learned from these techniques passed to the non-CTO PCI field dramatically increasing effectiveness and safety. CTOs are not anymore an isolated anatomic entity but the leading edge of the complex PCI field and as such should be considered and evolve further in parallel with technological evolution.
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